Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127426111 | 12742611 | 1 | I | 20160210 | 20160831 | 20160914 | 20160914 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-072693 | BRISTOL MYERS SQUIBB | 85.77 | YR | F | Y | 0.00000 | 20160914 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127426111 | 12742611 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 2 MG, BID | U | 9218 | 2 | MG | TABLET | BID | |||||
| 127426111 | 12742611 | 2 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | FILM-COATED TABLET | QD | ||||||
| 127426111 | 12742611 | 3 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 127426111 | 12742611 | 4 | C | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | U | 0 | ||||||||||
| 127426111 | 12742611 | 5 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 127426111 | 12742611 | 6 | C | ALDACTONE | SPIRONOLACTONE | 1 | Unknown | U | 0 | ||||||||||
| 127426111 | 12742611 | 7 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | U | 0 | ||||||||||
| 127426111 | 12742611 | 8 | C | BISOCE | BISOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 127426111 | 12742611 | 9 | C | DUPHALAC | LACTULOSE | 1 | Unknown | U | 0 | ||||||||||
| 127426111 | 12742611 | 10 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127426111 | 12742611 | 11 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127426111 | 12742611 | 1 | Pulmonary embolism |
| 127426111 | 12742611 | 2 | Myocardial infarction |
| 127426111 | 12742611 | 3 | Myocardial infarction |
| 127426111 | 12742611 | 4 | Product used for unknown indication |
| 127426111 | 12742611 | 5 | Product used for unknown indication |
| 127426111 | 12742611 | 6 | Product used for unknown indication |
| 127426111 | 12742611 | 7 | Product used for unknown indication |
| 127426111 | 12742611 | 8 | Product used for unknown indication |
| 127426111 | 12742611 | 9 | Constipation |
| 127426111 | 12742611 | 10 | Product used for unknown indication |
| 127426111 | 12742611 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127426111 | 12742611 | OT |
| 127426111 | 12742611 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127426111 | 12742611 | Acute coronary syndrome | |
| 127426111 | 12742611 | Anaemia | |
| 127426111 | 12742611 | Angiodysplasia | |
| 127426111 | 12742611 | Gastrointestinal haemorrhage | |
| 127426111 | 12742611 | Melaena | |
| 127426111 | 12742611 | Transfusion | |
| 127426111 | 12742611 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127426111 | 12742611 | 2 | 20160215 | 0 | ||
| 127426111 | 12742611 | 3 | 20160215 | 0 |